Tag: GLP-1
MindRank hands China rights to its AI-designed obesity pill
The Hangzhou biotech gives two 3SBio units exclusive China commercialization for MDR-001 in a deal worth up to RMB 1.75B.
AI nutrition duo merges to chase insured GLP-1 weight care
Healthify and Berry Street merge to build an insurance-covered AI metabolic care platform for the GLP-1 era.